Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
3.160
+0.010 (0.32%)
At close: Jun 22, 2026, 4:00 PM EDT
3.160
0.00 (-0.01%)
After-hours: Jun 22, 2026, 7:49 PM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $813.48 million as of June 22, 2026. Its market cap has increased by 253.84% in one year.
Market Cap
813.48M
Enterprise Value
1.20B
1-Year Change
253.84%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $813.48M, an increase of 298.57%. That is a compound annual growth rate of 11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 813.48M | -8.03% |
| Dec 31, 2025 | 884.50M | 104.04% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
| Jun 26, 2013 | 204.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.20B |
| Collegium Pharmaceutical | 1.09B |
| Cronos Group | 1.00B |
| Evotec SE | 943.89M |
| BioAge Labs | 923.28M |
| Eton Pharmaceuticals | 889.70M |
| Pacira BioSciences | 878.64M |
| Amphastar Pharmaceuticals | 829.39M |